Physician
Cardiology
Dr. Ronald S. Freudenberger, MD
|
|
Give Review
Ronald Freudenberger works in the field of Cardiology. He studied medicine at Mount Sinai School of Medicine. He has 1 awards "Fellow (FACC)". Ronald S. Freudenberger is a published MD. He published 56 publications, including: 'Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.' Ronald Freudenberger accepts all Medicare patients.
Publications
- National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.
- The first prognostic model for stroke and death in patients with systolic heart failure.
- Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
- Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.
- Benefit of Warfarin Compared with Aspirin in Heart Failure Patients in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial.
- Atrial fibrillation following cardiac surgery: established and emerging strategies of prevention.
- Suppression of ventricular tachycardia with dronedarone: a case report.
- Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
- Sleep disordered breathing, daytime symptoms, and functional performance in stable heart failure.
- What is the appropriate approach to prevention of thromboembolism in heart failure?
- Panel-reactive screening and treatment practices following bridge to transplantation ventricular assist device placement.
- Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking.
- Right heart pressure increases after acute increases in ambient particulate concentration.
- Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm.
- Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
- What do we know about anticoagulation in patients with heart failure?
- Acute electromechanical effects of atrioventricular coupled pacing in patients with heart failure.
- Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
- Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient.
- Beta-blocker contraindications: are there patients or situations where use is inappropriate?
- Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
- Should we use anticoagulation for patients with chronic heart failure?
- Psychological and social factors that correlate with dyspnea in heart failure.
- Optimal medical therapy is superior to transplantation for the treatment of class I, II, and III heart failure: a decision analytic approach.
- Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: a case report and review of the literature.
- Thoracic organ transplantation in the United States, 1995-2004.
- A call to disarm: is malignancy higher in post-transplant patients?
- Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
- Silent cerebral infarction in heart failure: vascular or thromboembolic?
- Permanent pacing is a risk factor for the development of heart failure.
- Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
- Influence of age, gender, and race on depression in heart failure patients.
- Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.
- Anomalous coronary artery in a transplanted heart: a technical modification.
- Policies of U.S. heart transplant programs regarding transplantation of human immunodeficiency-positive patients.
- Electrocardiogram and clinical characteristics of patients referred for cardiac transplantation: implications for pacing in heart failure.
- Ephedra-associated cardiomyopathy.
- Is there an optimal hemoglobin value in the cardiac intensive care unit?
- Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure.
- Characteristics of patients referred for cardiac transplantation: implications for the donor organ shortage.
- The effect of coenzyme Q10 in patients with congestive heart failure.
- Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
- Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure.
- Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy.
- Effects of exercise training on peak performance and quality of life in congestive heart failure patients.
- A four-part regimen for clinical heart failure.
- Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
- Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone.
- Therapeutic options in advanced heart failure.
- Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
- Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
- Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure.
- Intestinal infarction after intravenous cocaine administration.
- The Current Approach to Diagnosis and Management of Left Ventricular Noncompaction Cardiomyopathy: Review of the Literature.
- Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mount Sinai School of Medicine -
UMDNJ-Robert Wood Johnson Medical School -
State University of New York Upstate Medical University
Drug Facts
| NPI NUMBER | 1750451332 | |
| NPPES Provider LastName | FREUDENBERGER | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 181036224 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1366.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750451332 |
| Last Name Of The Provider | FREUDENBERGER |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
Dr. Gregory T. Altemose, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. James A. Burke, MD |
|
Dr. Syed A. Subzposh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan W. Kluck, DO |
|
Dr. Shameer Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Gulotta, MD |
|
|
Dr. Eugene E. Ordway Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jamie D. Paranicas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven L. Zelenkofske, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman S. Sarachek, MD |
|
Dr. Larry E. Jacobs, MD |